Used as a prodrug of dexamethasone, it is designed to improve lipophilicity and tissue penetration. This allows for prolonged anti-inflammatory effects, especially in targeted therapies. Commonly applied in ophthalmic formulations to treat inflammatory eye conditions due to its sustained release profile. Also investigated for use in corticosteroid therapies requiring slow systemic release, reducing dosing frequency. Its esterified form enhances stability in formulations and enables incorporation into lipid-based delivery systems such as emulsions or nanoparticles.